PRESS RELEASE published on 11/04/2024 at 08:11, 5 months 3 days ago Original-Research: Surteco Group SE (von Sphene Capital GmbH): Buy Einstufung von Sphene Capital GmbH zu Surteco Group SE: Update Report empfiehlt Kauf mit Kursziel EUR 26,10. Neunmonatsbericht 2024 zeigt Ergebnisverbesserung um 63,1% Kaufempfehlung Sphene Capital GmbH SURTECO GROUP SE Ergebnisverbesserung Neunmonatsbericht
BRIEF published on 10/31/2024 at 07:35, 5 months 7 days ago SURTECO Achieves Forecasted Growth Amidst Challenging Conditions Financial Results Sales Growth EBITDA Increase SURTECO Cost Management
BRIEF published on 10/31/2024 at 07:35, 5 months 7 days ago SURTECO réalise la croissance prévue dans des conditions difficiles Résultats Financiers Croissance Des Ventes Gestion Des Coûts SURTECO Augmentation De L'EBITDA
PRESS RELEASE published on 10/31/2024 at 07:30, 5 months 7 days ago SURTECO GROUP SE: Sales and earnings within the forecast range in spite of difficult framework conditions SURTECO GROUP SE reports sales and earnings within forecast range despite challenging conditions. Adjusted EBITDA up by +20% to €76.8 million Sales Adjusted EBITDA Earnings SURTECO GROUP SE Forecast Range
BRIEF published on 10/04/2024 at 09:00, 6 months 3 days ago Banasino Investments Gains Control Over Surteco Group SE Acquisition Mandatory Offer SURTECO GROUP SE Banasino Investments German Securities Law
BRIEF published on 10/04/2024 at 09:00, 6 months 3 days ago Banasino Investments prend le contrôle de Surteco Group SE Acquisition Offre Obligatoire Investissements Banasino Groupe Surteco SE Droit Allemand Des Valeurs Mobilières
PRESS RELEASE published on 10/04/2024 at 08:55, 6 months 3 days ago EQS-WpÜG: Attainment of Control / Target company: Surteco Group SE; Bidder: Banasino Investments S.a r.l. Banasino Investments S.a r.l acquires control over Surteco Group SE through share acquisition. Mandatory Offer to be made to shareholders Share Acquisition Mandatory Offer SURTECO GROUP SE Control Banasino Investments
PRESS RELEASE published on 08/01/2024 at 08:31, 8 months 6 days ago Original-Research: Surteco Group SE (von Sphene Capital GmbH): Buy Sphene Capital GmbH stuft Surteco Group SE positiv ein und bestätigt ein Kursziel von EUR 26,80. Die Halbjahreszahlen 2024 zeigen eine deutliche Steigerung des Umsatzes und des bereinigten EBITDA Kursziel Sphene Capital GmbH SURTECO GROUP SE Halbjahreszahlen 2024 EBITDA-Steigerung
BRIEF published on 07/31/2024 at 07:35, 8 months 7 days ago SURTECO Group SE annonce une forte croissance de ses ventes et de ses bénéfices Performance Financière Prévisions 2024 BAIIA La Croissance Des Ventes SURTECO Groupe SE
BRIEF published on 07/31/2024 at 07:35, 8 months 7 days ago SURTECO Group SE Reports Strong Growth in Sales and Earnings EBITDA Financial Performance Sales Growth 2024 Forecast SURTECO GROUP SE
Published on 04/07/2025 at 08:00, 3 hours 50 minutes ago Pulsar Helium Announces Notice of 2025 Annual General and Special Meeting of Shareholders
Published on 04/07/2025 at 00:05, 11 hours 45 minutes ago Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
Published on 04/05/2025 at 01:50, 2 days 10 hours ago Battery X Metals Achieves Graphite Recovery Breakthrough in Partnership with Global Top 20 University in Controlled Trials
Published on 04/07/2025 at 11:18, 31 minutes ago Cerinnov Group: DECLARATION MENSUELLE DU NOMBRE D’ACTIONS ET DE DROITS DE VOTES
Published on 04/07/2025 at 10:30, 1 hour 19 minutes ago Original-Research: UmweltBank AG (von GBC AG): Buy
Published on 04/07/2025 at 09:06, 2 hours 43 minutes ago A taboo subject: Younger people talk more openly about their salary than older people — but shy away from negotiation
Published on 04/07/2025 at 09:00, 2 hours 49 minutes ago Original-Research: Borussia Dortmund GmbH & Co KGaA (von NuWays AG): BUY
Published on 04/07/2025 at 09:00, 2 hours 50 minutes ago Julius Meinl Living Publishes its Consolidated 2024 Accounts
Published on 04/07/2025 at 07:01, 4 hours 49 minutes ago bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 4 hours 49 minutes ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 16 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 16 hours ago Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 17 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
